• Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Given Average Recommendation of "Moderate Buy" by Brokerages

    Source: Buzz FX / 26 Nov 2024 01:36:10   America/Chicago


    Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Given Average Recommendation of "Moderate Buy" by Brokerages Written by MarketBeat November 26, 2024 Share Link copied to clipboard. Shares of Neurocrine Biosciences, Inc.
    Read more...
Share on,